Eascra Biotech
Boston · Founded 2022
About Eascra Biotech
Eascra Biotech creates Janus base nanomaterials based on DNA nanotechnology that are highly effective and super biocompatible for articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions. Its three generations of DNA-inspired nanotubes are a low-cost, scalable alternative to existing options. Its Janus nanotechnologies can be tailored to improve the therapeutic efficacy of drug treatments for a variety of chronic conditions and medical needs.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.2M
- Last round: Grant (May 2025)
- Website: https://eascrabiotech.com/
- Phone: 1.401.286.9828
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/eascra-biotech-49434 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.